MA04.02 Responses and Durability in NSCLC Treated With Pegilodecakin and Anti-Pd-1
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.341
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV